Metformin/sulfonylureas

Detailed article on Metformin and Sulfonylureas

Synonyms

Metformin/Sulfonylureas

Drug Information
Image	250
Identifiers CAS Number ATC Code PubChem DrugBank ChemSpider ID UNII KEGG ChEBI ChEMBL IUPAC Name		Chemical Data C H N O Molecular Weight

Metformin and sulfonylureas are two classes of oral medications commonly used in the management of type 2 diabetes mellitus. These medications help control blood glucose levels through different mechanisms of action and are often used in combination to achieve better glycemic control.

Mechanism of Action

Metformin

Metformin is a biguanide that primarily works by decreasing hepatic glucose production, particularly by inhibiting gluconeogenesis in the liver. It also improves insulin sensitivity by increasing peripheral glucose uptake and utilization, particularly in muscle tissue. Metformin does not stimulate insulin secretion, which reduces the risk of hypoglycemia compared to other antidiabetic agents.

Sulfonylureas

Sulfonylureas, such as glipizide, glyburide, and glimepiride, function by stimulating the pancreatic beta cells to secrete more insulin. They bind to the sulfonylurea receptor on the beta cell membrane, leading to closure of ATP-sensitive potassium channels, depolarization of the cell membrane, and subsequent opening of voltage-gated calcium channels. The influx of calcium ions triggers insulin release.

Clinical Use

Indications

Both metformin and sulfonylureas are indicated for the management of type 2 diabetes mellitus, particularly in patients who are unable to achieve adequate glycemic control with lifestyle modifications alone.

Combination Therapy

Metformin is often used as first-line therapy due to its efficacy, safety profile, and cardiovascular benefits. Sulfonylureas may be added as a second-line therapy when metformin alone is insufficient to achieve target blood glucose levels. The combination of metformin and sulfonylureas can be particularly effective due to their complementary mechanisms of action.

Side Effects

Metformin

Common side effects of metformin include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort. A rare but serious side effect is lactic acidosis, particularly in patients with renal impairment or other risk factors.

Sulfonylureas

The primary side effect of sulfonylureas is hypoglycemia, which can be severe. Weight gain is also a common side effect, as these drugs increase insulin levels.

Contraindications

Metformin

Metformin is contraindicated in patients with severe renal impairment, acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in those with a history of hypersensitivity to the drug.

Sulfonylureas

Sulfonylureas are contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, and in those with a known hypersensitivity to sulfonylureas.

Also see

• Type 2 diabetes mellitus
• Insulin therapy
• Biguanides
• Hypoglycemia
• Glycemic control